Metoject®

INN: methotrexate sodium

Approved for use in:

Crohn’s Disease (moderate-severe)
Ulcerative Colitis (moderate-severe)

Type/Class

Immunomodulator

Delivery Route

Subcutaneous Injection

Health Canada Approval

2016

Storage

Store between 15 and 25°C in original carton, keep away from heat and light, avoid freezing, and properly discard of medicine in sharps container when expired or no longer needed.

Use in Older Adults (65+)

May be used; monitor hepatic and renal function.

Pregnancy Indication

Can cause fetal death; avoid when possible.

Breastfeeding Indication

Not recommended.

Pediatric Indication

Safety and efficacy not established.

Learn More

View the Metoject® product monograph.